These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

239 related items for PubMed ID: 11768137

  • 1. Associations between phenylalanine-to-tyrosine ratios and performance on tests of neuropsychological function in adolescents treated early and continuously for phenylketonuria.
    Luciana M, Sullivan J, Nelson CA.
    Child Dev; 2001; 72(6):1637-52. PubMed ID: 11768137
    [Abstract] [Full Text] [Related]

  • 2. Prefrontal cortex cognitive deficits in children treated early and continuously for PKU.
    Diamond A, Prevor MB, Callender G, Druin DP.
    Monogr Soc Res Child Dev; 1997; 62(4):i-v, 1-208. PubMed ID: 9421921
    [Abstract] [Full Text] [Related]

  • 3. A preliminary investigation of the role of the phenylalanine:tyrosine ratio in children with early and continuously treated phenylketonuria: toward identification of "safe" levels.
    Sharman R, Sullivan K, Young R, McGill J.
    Dev Neuropsychol; 2010; 35(1):57-65. PubMed ID: 20390592
    [Abstract] [Full Text] [Related]

  • 4. Cerebral dopamine deficiency, plasma monoamine alterations and neurocognitive deficits in adults with phenylketonuria.
    Boot E, Hollak CEM, Huijbregts SCJ, Jahja R, van Vliet D, Nederveen AJ, Nieman DH, Bosch AM, Bour LJ, Bakermans AJ, Abeling NGGM, Bassett AS, van Amelsvoort TAMJ, van Spronsen FJ, Booij J.
    Psychol Med; 2017 Dec; 47(16):2854-2865. PubMed ID: 28552082
    [Abstract] [Full Text] [Related]

  • 5. Mental health and social functioning in early treated Phenylketonuria: the PKU-COBESO study.
    Jahja R, Huijbregts SC, de Sonneville LM, van der Meere JJ, Bosch AM, Hollak CE, Rubio-Gozalbo ME, Brouwers MC, Hofstede FC, de Vries MC, Janssen MC, van der Ploeg AT, Langendonk JG, van Spronsen FJ.
    Mol Genet Metab; 2013 Dec; 110 Suppl():S57-61. PubMed ID: 24183792
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A preliminary report on dopamine system reactivity in PKU: acute effects of haloperidol on neuropsychological, physiological, and neuroendocrine functions.
    Luciana M, Hanson KL, Whitley CB.
    Psychopharmacology (Berl); 2004 Aug; 175(1):18-25. PubMed ID: 15024549
    [Abstract] [Full Text] [Related]

  • 10. Depressive symptoms in adolescents with early and continuously treated phenylketonuria: associations with phenylalanine and tyrosine levels.
    Sharman R, Sullivan K, Young RM, McGill J.
    Gene; 2012 Aug 10; 504(2):288-91. PubMed ID: 22609065
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Neurocognitive functioning in adults with phenylketonuria: Report of a 10-year follow-up.
    Feldmann R, Osterloh J, Onon S, Fromm J, Rutsch F, Weglage J.
    Mol Genet Metab; 2019 Mar 10; 126(3):246-249. PubMed ID: 30598390
    [Abstract] [Full Text] [Related]

  • 13. Cognitive profile and mental health in adult phenylketonuria: A PKU-COBESO study.
    Jahja R, Huijbregts SCJ, de Sonneville LMJ, van der Meere JJ, Legemaat AM, Bosch AM, Hollak CEM, Rubio-Gozalbo ME, Brouwers MCGJ, Hofstede FC, de Vries MC, Janssen MCH, van der Ploeg AT, Langendonk JG, van Spronsen FJ.
    Neuropsychology; 2017 May 10; 31(4):437-447. PubMed ID: 28318283
    [Abstract] [Full Text] [Related]

  • 14. The influence of blood phenylalanine levels on neurocognitive function in adult PKU patients.
    Bartus A, Palasti F, Juhasz E, Kiss E, Simonova E, Sumanszki C, Reismann P.
    Metab Brain Dis; 2018 Oct 10; 33(5):1609-1615. PubMed ID: 29948654
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Emotional health in early-treated adults with phenylketonuria (PKU): Relationship with cognitive abilities and blood phenylalanine.
    Palermo L, MacDonald A, Limback E, Robertson L, Howe S, Geberhiwot T, Romani C.
    J Clin Exp Neuropsychol; 2020 Mar 10; 42(2):142-159. PubMed ID: 31790339
    [Abstract] [Full Text] [Related]

  • 18. Intellectual, neurologic, and neuropsychologic outcome in untreated subjects with nonphenylketonuria hyperphenylalaninemia. German Collaborative Study on Phenylketonuria.
    Weglage J, Ullrich K, Pietsch M, Fünders B, Güttler F, Harms E.
    Pediatr Res; 1997 Sep 10; 42(3):378-84. PubMed ID: 9284280
    [Abstract] [Full Text] [Related]

  • 19. The impact of phenylalanine levels on cognitive outcomes in adults with phenylketonuria: Effects across tasks and developmental stages.
    Romani C, Palermo L, MacDonald A, Limback E, Hall SK, Geberhiwot T.
    Neuropsychology; 2017 Mar 10; 31(3):242-254. PubMed ID: 28240926
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.